Chlorophyll and chlorophyllin aren't the same molecule. Chlorophyll is what makes plants green. Chlorophyllin, the version in the drops and capsules, swaps the magnesium for copper and cuts the fatty tail off, so it dissolves in water and survives your stomach.
The one thing it does is physical. It's a flat ring, and it binds other flat rings: aflatoxin (a mould toxin on badly-stored peanuts and corn), the heterocyclic amines from charred meat, the carcinogens in smoke. The pair is too big and too water-loving to cross out of your intestine, so it leaves in stool 1. That's the whole mechanism: it works in the gut, on the toxin arriving in the same meal. It can't reach anything already absorbed, stored in fat, or outside the intestine.
One trial carries the entire case. In a Chinese region with extreme dietary aflatoxin, chlorophyllin cut the DNA-bound aflatoxin marker by about half 2. That marker isn't cancer, and no study has ever carried it to a hard endpoint or repeated it where exposure is normal. Everything else the drops are sold for is thinner: the oral deodorant claim failed its one controlled trial 3, and swallowed chlorophyll has never been tested for skin at all. The skin signal that exists is for a topical cream, in studies under fifteen people with industry funding 4.
Only two situations justify buying it. Screen yourself first, then dose it right.
Cheap, and mostly the same everywhere. Drops or capsules run $10 to $20 a month, the cream $30 to $60. A cup of cooked spinach carries roughly 70 mg of chlorophyll, so a day of greens is near the trial dose by mass, but as chlorophyll, which digestion breaks down harder than the stabilized chlorophyllin form. Eat the greens for nutrition; they don't replace the capsule on the one job it actually has.
The fine print — when to skip it, and what people get wrong
"Oxygenates your blood": no — it carries no oxygen and is destroyed in your gut 5. "Detoxes you": no; it binds gut toxins, it doesn't cleanse a liver. "Alkalizes you": no; blood pH is fixed near 7.4 whatever you eat.
It's an FDA food colour with a benign record. Still skip in pregnancy or breastfeeding (untested) and in porphyria. Space it an hour or two from meal-time prescription drugs. Green stools and urine are expected.
Most people quit disappointed: they bought it for skin or "detox," saw only green urine, and blamed the dose. The gut-binding effect was working; they never measured it. The other common miss is taking it away from food, so binder and toxin never meet.
- 1Jubert et al. (2009). Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B1 pharmacokinetics in human volunteers. Cancer Prevention Research. link
- 2Egner et al. (2001). Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proceedings of the National Academy of Sciences. link
- 3Christiansen TA, Pickrel HE (1964). Chlorophyllin: An evaluation of its effectiveness as an oral deodorant. Journal of the American Medical Association. link
- 4Stephens et al. (2015). Pilot Study to Evaluate the Effects of Topically Applied Chlorophyllin-Copper Complex on the Improvement of Photodamaged Skin. Journal of Drugs in Dermatology. link
- 5Yang Y, Misra BB, Liang L et al. (2014). Integrated phylotranscriptomic analysis reveals biosynthetic and pharmacological aspects of chlorophyll catabolism. Nutrients. link
Chlorophyll and Chlorophyllin
Liquid drops and capsules retail $10–30/month in the US; topical chlorophyllin-copper creams $30–60. Trivial relative to most supplement-aisle interventions.
Drops or capsules with meals; no protocol harder than remembering. The mechanistic with-meals timing is the only friction worth noting.
One well-conducted RCT (Egner 2001) with biomarker endpoint plus one human pharmacokinetic confirmation (Jubert 2009) for the aflatoxin-binding mechanism; small open-label industry pilots for topical skin (Stephens 2015, Sigler 2015); a failed 1964 RCT for the deodorant claim; nothing controlled for the most-marketed oral-skin and detox claims.
Topical chlorophyllin-copper pilot trials (Stephens 2015, Sigler 2015) show mild improvement in photodamage and acne, but trials are small, open-label, and industry-supported. The oral form — the one the TikTok cycle drove — has zero controlled trial support for any skin endpoint.
Egner et al. 2001 (PNAS) showed a 55% reduction in urinary aflatoxin-N7-guanine adducts with 100 mg chlorophyllin three times daily in high-exposure Qidong adults. The mechanism is real and narrow — meaningful for high-aflatoxin or heavily-charred-meat populations, marginal for typical low-exposure adults. No mortality endpoint trial exists.